Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Capital Gains tax rules effective 2024 CRA

<< Previous

Bullboard Posts

Next >>

Post by james700on Jun 21, 2023 9:36pm

479 Views

Post# 35508325

New Capital Gains tax rules effective 2024 CRA

This appeared in the financial post. Looks like we are going to be paying for the pandemic spending spree.

https://financialpost.com/personal-finance/taxes/alternative-minimum-tax-system-changes-affect-canadians/wcm/a3626eec-19bc-4654-a082-8f482eee3ccf/amp/

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports